What is the acute management of hereditary hemorrhagic telangiectasia (HHT) epistaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Management of HHT Epistaxis

For acute HHT epistaxis, apply direct nasal compression first, then use topical antifibrinolytics or gelatin sponge soaked in adrenaline, avoiding nasal packing and electrocautery which cause further vascular trauma. 1

Immediate Hemorrhage Control

First-Line Acute Measures

  • Apply direct compression to the nose as the initial step to control active bleeding 1
  • Use topical antifibrinolytics applied directly to bleeding sites for hemostasis 1
  • Apply gelatin sponge soaked in adrenaline to bleeding telangiectasias 1
  • Consider fibrin sealant spray for localized bleeding control 1

What to Avoid in Acute Settings

  • Do not use traditional nasal packing as it causes additional trauma to fragile telangiectatic vessels and worsens subsequent bleeding 1
  • Avoid electrocauterization during acute episodes as it damages surrounding vascular tissue and promotes more telangiectasia formation 1

Severe Acute Hemorrhage Protocol

When Simple Measures Fail

  • For heavy acute epistaxis unresponsive to compression and topical measures, use an epistaxis balloon combined with artery ligation and/or embolization as the most effective treatment 1
  • Laser therapy (argon, Nd:YAG, KTP/532, or diode—not CO2) can be used during acute episodes if equipment and expertise are available 1
  • Argon plasma coagulation therapy provides effective acute hemostasis 1

Transition to Ongoing Management

After Acute Control

  • Once acute bleeding is controlled, immediately initiate nasal moisturization with saline gels and humidification to prevent recurrent episodes 2
  • Consider starting oral tranexamic acid (500 mg twice daily, gradually increasing to 1000 mg four times daily) for patients with recurrent episodes, unless contraindicated by recent thrombosis 3

Key Clinical Pitfall

The most common error in acute HHT epistaxis management is using aggressive nasal packing and cautery—the same techniques effective for non-HHT epistaxis—which paradoxically worsen outcomes by traumatizing the abnormal vasculature and accelerating telangiectasia formation 1. The principle is "do as little as possible for as long as possible" while achieving hemostasis 1.

Monitoring During Acute Episodes

  • Assess hemodynamic stability and need for transfusion support in severe bleeding 4
  • Check hemoglobin levels as patients with HHT average up to 18 bleeds per month and can develop severe anemia 4

References

Guideline

Treatment of Hereditary Hemorrhagic Telangiectasia Epistaxis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.